|
22
|
92
|
6u36A |
Pcsk9 in complex with a fab and compound 14 |
|
41
|
219
|
6u38H |
Pcsk9 in complex with a fab and compound 8 |
|
37
|
210
|
6u38L |
Pcsk9 in complex with a fab and compound 8 |
|
41
|
210
|
6u36L |
Pcsk9 in complex with a fab and compound 14 |
|
39
|
218
|
6u36H |
Pcsk9 in complex with a fab and compound 14 |
|
21
|
92
|
6u38A |
Pcsk9 in complex with a fab and compound 8 |
|
29
|
111
|
6jszD |
Bace2 xaperone complex with n-{3-[(5r)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide |
|
90
|
386
|
6jszA |
Bace2 xaperone complex with n-{3-[(5r)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide |
|
44
|
203
|
5l0qA |
Crystal structure of the complex between adam10 d+c domain and a conformation specific mab 8c7. |
|
52
|
212
|
5l0qB |
Crystal structure of the complex between adam10 d+c domain and a conformation specific mab 8c7. |
|
44
|
220
|
5l0qC |
Crystal structure of the complex between adam10 d+c domain and a conformation specific mab 8c7. |
|
31
|
127
|
5j57B |
V5e1-rta complex |
|
88
|
255
|
5j56A |
Rta-v1c7 |
|
36
|
129
|
5j56B |
Rta-v1c7 |
|
223
|
966
|
6bf7A |
Cryo-em structure of human insulin degrading enzyme in complex with fab h11-e heavy chain, fab h11-e light chain |
|
211
|
966
|
6bf9A |
Cryo-em structure of human insulin degrading enzyme in complex with fab h11-e heavy chain, fab h11-e light chain |
|
28
|
211
|
6bf9D |
Cryo-em structure of human insulin degrading enzyme in complex with fab h11-e heavy chain, fab h11-e light chain |
|
204
|
966
|
6b7zA |
Cryo-em structure of human insulin degrading enzyme in complex with fab h11 heavy chain and fab h11 light chain |
|
32
|
211
|
6b7zD |
Cryo-em structure of human insulin degrading enzyme in complex with fab h11 heavy chain and fab h11 light chain |
|
34
|
211
|
6bf7D |
Cryo-em structure of human insulin degrading enzyme in complex with fab h11-e heavy chain, fab h11-e light chain |
|
28
|
218
|
6bf9C |
Cryo-em structure of human insulin degrading enzyme in complex with fab h11-e heavy chain, fab h11-e light chain |
|
30
|
218
|
6bf7C |
Cryo-em structure of human insulin degrading enzyme in complex with fab h11-e heavy chain, fab h11-e light chain |
|
31
|
218
|
6b7zC |
Cryo-em structure of human insulin degrading enzyme in complex with fab h11 heavy chain and fab h11 light chain |
|
44
|
127
|
5vjoE |
Complex between hyhel10 fab fragment heavy chain mutant i29f and pekin duck egg lysozyme isoform i (del-i) |
|
44
|
222
|
5vpgD |
Crystal structure of der p 1 complexed with fab 4c1 |
|
49
|
211
|
5vpgC |
Crystal structure of der p 1 complexed with fab 4c1 |
|
61
|
223
|
5vplA |
Crystal structure of der f 1 complexed with fab 4c1 |
|
64
|
222
|
5vphA |
Crystal structure of der p 1 complexed with fab 4c1 |
|
55
|
211
|
5vplC |
Crystal structure of der f 1 complexed with fab 4c1 |
|
44
|
222
|
5vplD |
Crystal structure of der f 1 complexed with fab 4c1 |
|
51
|
212
|
5vjqB |
Complex between hyhel10 fab fragment heavy chain mutant (i29f, s52t, y53f) and pekin duck egg lysozyme isoform i (del-i) |
|
40
|
212
|
5bv7B |
Crystal structure of human lcat (l4f, n5d) in complex with fab of an agonistic antibody |
|
46
|
210
|
5bv7L |
Crystal structure of human lcat (l4f, n5d) in complex with fab of an agonistic antibody |
|
46
|
228
|
5bv7H |
Crystal structure of human lcat (l4f, n5d) in complex with fab of an agonistic antibody |
|
42
|
225
|
5bv7C |
Crystal structure of human lcat (l4f, n5d) in complex with fab of an agonistic antibody |
|
120
|
396
|
5bv7A |
Crystal structure of human lcat (l4f, n5d) in complex with fab of an agonistic antibody |
|
22
|
126
|
5bozG |
Ricin a chain bound to camelid nanobody (vhh9)(e1) |
|
90
|
259
|
5bozA |
Ricin a chain bound to camelid nanobody (vhh9)(e1) |
|
313
|
1021
|
4ckdA |
Model of complex between the e.coli enzyme beta-galactosidase and four single chain fv antibody domains scfv13r4. |
|
46
|
224
|
4qnpE |
Crystal structure of the 2009 pandemic h1n1 influenza virus neuraminidase with a neutralizing antibody |
|
45
|
215
|
4dw2L |
The crystal structure of upa in complex with the fab fragment of mab-112 |
|
38
|
212
|
4dw2H |
The crystal structure of upa in complex with the fab fragment of mab-112 |
|
38
|
241
|
4dw2U |
The crystal structure of upa in complex with the fab fragment of mab-112 |
|
50
|
213
|
4d9qD |
Inhibiting alternative pathway complement activation by targeting the exosite on factor d |
|
58
|
228
|
4d9qA |
Inhibiting alternative pathway complement activation by targeting the exosite on factor d |
|
41
|
217
|
4d9qE |
Inhibiting alternative pathway complement activation by targeting the exosite on factor d |
|
50
|
213
|
4d9rD |
Inhibiting alternative pathway complement activation by targeting the exosite on factor d |
|
59
|
228
|
4d9rA |
Inhibiting alternative pathway complement activation by targeting the exosite on factor d |
|
41
|
216
|
4d9rE |
Inhibiting alternative pathway complement activation by targeting the exosite on factor d |
|
29
|
114
|
4ckdH |
Model of complex between the e.coli enzyme beta-galactosidase and four single chain fv antibody domains scfv13r4. |
